Crohn's disease and ulcerative colitis represent the two main forms of the idiopathic chronic
inflammatory bowel diseases (IBD). Currently available blood and stool based biomarkers …

Diagnosis and prognosis of inflammatory bowel disease (IBD)—a chronic inflammation that
affects the gastrointestinal tract of patients—are challenging, as most clinical symptoms are …

Diagnostics of inflammatory bowel diseases (IBDs) currently relies on a combination of
biological and morphological tests. The current method of diagnostic remains a critical …

Fecal and serologic biomarkers can be used in the diagnosis and management of
inflammatory bowel disease (IBD). Fecal markers such as calprotectin and lactoferrin have …

Recent observations suggest that subjective measures of disease activity in inflammatory
bowel disease (IBD) are often misleading. Objective measures of inflammation are more …

Background: Inflammatory bowel disease (IBD), including Crohn's disease and ulcerative
colitis, is a chronic, inflammatory disorder of the gastrointestinal tract. As the novel …

The biomarkers are important in the Inflammatory Bowel Disease (IBD) to gain an objective
measurement of disease activity and severity, as well as prognostic indicator and outcome of …

There is currently no gold standard test for the diagnosis of inflammatory bowel disease
(IBD). Physicians must rely on a number of diagnostic tools including clinical and …

Unambiguous diagnosis of the two main forms of inflammatory bowel diseases (IBD):
Ulcerative colitis (UC) and Crohn's disease (CD), represents a challenge in the early stages …

Background: Inflammatory bowel disease (IBD) is a chronically relapsing disease with a
continuous need for proactive monitoring to decide appropriate treatments and follow-up …